Frank Morgan
Bio
Stories (88)
Filter by community
Psoriatic Arthritis Treatment Market Size to Reach USD 23.2 Billion by 2033
The global psoriatic arthritis treatment market size reached USD 10.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 23.2 Billion by 2033, exhibiting a growth rate (CAGR) of 8.71% during 2025-2033. The increasing prevalence of psoriasis disease due to infection, stress, obesity, skin injuries, alcohol abuse, and vitamin deficiencies represents one of the primary factors influencing the market positively.
By Frank Morgan5 months ago in Journal
Sports Nutrition Market Size to Reach USD 104.65 Billion by 2033
The global sports nutrition market size was valued at USD 58.72 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 104.65 Billion by 2033, exhibiting a CAGR of 6.58% during 2025-2033. The market is witnessing steady growth due to a growing emphasis on health and fitness lifestyles, heightened awareness of the significance of protein intake and supplementation for muscle recovery and overall performance and the swift expansion of ecommerce platforms and online retail channels.
By Frank Morgan5 months ago in Journal
Pain Management Drugs Market Size to Reach USD 88.7 Billion by 2033
The global pain management drugs market size reached USD 71.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 88.7 Billion by 2033, exhibiting a growth rate (CAGR) of 2.32% during 2025-2033. The market is experiencing robust growth driven by the increasing prevalence of chronic diseases, rapid advancements in pain management therapies.
By Frank Morgan5 months ago in Journal
Liver Disease Treatment Market Size to Reach USD 40.4 Billion by 2033
The global liver disease treatment market size was valued at USD 25.10 Billion in 2024. The market is projected to reach USD 40.4 Billion by 2033, exhibiting a CAGR of 5.44% from 2025-2033. The market is driven by the rising prevalence of conditions, such as hepatitis, fatty liver disease, cirrhosis, and liver cancer, fueled by changing lifestyles, alcohol consumption, and increasing obesity rates.
By Frank Morgan5 months ago in Journal
AI in Drug Discovery Market Size, Trends, Scope, Demand, Opportunity, and Forecast by 2033
The global AI in drug discovery market size reached USD 1.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 14.0 Billion by 2033, exhibiting a growth rate (CAGR) of 23.17% during 2025-2033. Oncology dominates the market driven by the rising cancer prevalence drives demand for AI-based tools to identify new cancer therapies and personalize treatment approaches.
By Frank Morgan5 months ago in Journal
Gaucher Disease Market Outlook 2025: Trends, Innovations, and Growth Drivers
The gaucher disease market size reached a value of USD 1,218.7 Million in 2024. Looking forward, IMARC Group expects the 7MM to reach USD 1,394.6 Million by 2035, exhibiting a growth rate (CAGR) of 1.24% during 2025-2035. The Gaucher disease market in 2025 is evolving with new scientific advancements, improved diagnostics, and patient-focused care models. Gaucher disease is a rare inherited lysosomal storage disorder caused by a deficiency of the enzyme *lucocerebrosidase. The market includes enzyme replacement therapy (ERT), substrate reduction therapy (SRT), advanced gene and genome-editing technologies, diagnostic tools, and supportive care services aimed at improving long-term disease management.
By Frank Morgan6 months ago in Journal
Obesity Market Forecast: Tech-Driven Treatments & Growth Trends
In 2025, the obesity market is expanding steadily due to the global prevalence of obesity, rising awareness of health complications, and new treatment options. The World Health Organization (WHO) defines obesity as an excessive accumulation of body fat that poses a health risk. It is typically measured via the Body Mass Index (BMI) where a score of 30 and above is obesity. The condition increases the risk of serious chronic health conditions such as type 2 diabetes, heart disease, stroke, and certain cancers.
By Frank Morgan6 months ago in Journal
Delirium Market Outlook | Size, Drugs, Epidemiology Trends and Forecast to 2035
What is delirium? A delirium is a severe, acute change in mental status, characterised by disorganized thinking and reduced awareness of one's environment; delirium typically takes on an abrupt onset, usually in hours or days, and tends to be transient and reversible. There are three primary forms of delirium: hyperactive delirium, where the patient may be restless, agitated, or exhibit rapid shifts in mood; hypoactive delirium, where patients become lethargic, drowsy, or withdrawn; and mixed delirium, which is a fluctuation between both the hyperactive and hypoactive forms. Surprisingly, hypoactive delirium is rapidly gaining recognition for its emergent requirement for appropriate treatment, largely due to its often subtle presentation.
By Frank Morgan6 months ago in Journal
Head and Neck Cancer Market Outlook | Size, Drugs, Epidemiology Trends and Forecast to 2035
The Head and Neck Cancer (HNC) market encompasses therapeutic interventions for malignancies affecting areas such as the larynx, throat, lips, mouth, nose, and salivary glands. Valued at approximately USD 3,499.5 Million in 2024 and is projected to reach USD 8,228.2 Million by 2035, demonstrating a robust Compound Annual Growth Rate (CAGR) of 8.12% during 2025-2035.
By Frank Morgan6 months ago in Journal
